Application 021947
- Type
- NDA
- Sponsor
- CEPHALON
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FENTORA | FENTANYL CITRATE | TABLET;BUCCAL, SUBLINGUAL | EQ 0.1MG BASE | Yes | No |
| 002 | FENTORA | FENTANYL CITRATE | TABLET;BUCCAL, SUBLINGUAL | EQ 0.2MG BASE | Yes | No |
| 003 | FENTORA | FENTANYL CITRATE | TABLET;BUCCAL, SUBLINGUAL | EQ 0.4MG BASE | Yes | Yes |
| 004 | FENTORA | FENTANYL CITRATE | TABLET;BUCCAL, SUBLINGUAL | EQ 0.6MG BASE | Yes | No |
| 005 | FENTORA | FENTANYL CITRATE | TABLET;BUCCAL, SUBLINGUAL | EQ 0.8MG BASE | Yes | No |
| 006 | FENTORA | FENTANYL CITRATE | TABLET;BUCCAL, SUBLINGUAL | EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021947-001 | FENTORA | FENTANYL CITRATE | EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | |
| N021947-002 | FENTORA | FENTANYL CITRATE | EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | |
| N021947-003 | FENTORA | FENTANYL CITRATE | EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | |
| N021947-004 | FENTORA | FENTANYL CITRATE | EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | |
| N021947-005 | FENTORA | FENTANYL CITRATE | EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | |
| N021947-006 | FENTORA | FENTANYL CITRATE | EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2007-03-02 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N021947-001 | 7862832 | 2028-06-15 | Drug product | 2011-04-25 | |
| N021947-001 | 7862833 | 2028-06-15 | Drug product | 2011-04-25 | |
| N021947-002 | 7862832 | 2028-06-15 | Drug product | ||
| N021947-002 | 7862833 | 2028-06-15 | Drug product | ||
| N021947-003 | 7862832 | 2028-06-15 | Drug product | ||
| N021947-003 | 7862833 | 2028-06-15 | Drug product | ||
| N021947-004 | 7862832 | 2028-06-15 | Drug product | ||
| N021947-004 | 7862833 | 2028-06-15 | Drug product | ||
| N021947-005 | 7862832 | 2028-06-15 | Drug product | 2011-04-25 | |
| N021947-005 | 7862833 | 2028-06-15 | Drug product | 2011-04-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021947-001 | FENTORA | EQ 0.1MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021947-002 | FENTORA | EQ 0.2MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021947-003 | FENTORA | EQ 0.4MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021947-004 | FENTORA | EQ 0.6MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021947-005 | FENTORA | EQ 0.8MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021947-006 | FENTORA | EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2007-03-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-001 | FENTORA | EQ 0.1MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-002 | FENTORA | EQ 0.2MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-003 | FENTORA | EQ 0.4MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-004 | FENTORA | EQ 0.6MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-005 | FENTORA | EQ 0.8MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-006 | FENTORA | EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2007-03-02 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021947-001 | FENTORA | EQ 0.1MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021947-002 | FENTORA | EQ 0.2MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021947-003 | FENTORA | EQ 0.4MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021947-004 | FENTORA | EQ 0.6MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021947-005 | FENTORA | EQ 0.8MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021947-006 | FENTORA | EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2007-03-02 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-001 | FENTORA | EQ 0.1MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-002 | FENTORA | EQ 0.2MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-003 | FENTORA | EQ 0.4MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-004 | FENTORA | EQ 0.6MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-005 | FENTORA | EQ 0.8MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-006 | FENTORA | EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2007-03-02 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021947-001 | FENTORA | EQ 0.1MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021947-002 | FENTORA | EQ 0.2MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021947-003 | FENTORA | EQ 0.4MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021947-004 | FENTORA | EQ 0.6MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021947-005 | FENTORA | EQ 0.8MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021947-006 | FENTORA | EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2007-03-02 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021947-001 | FENTORA | EQ 0.1MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021947-002 | FENTORA | EQ 0.2MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021947-003 | FENTORA | EQ 0.4MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021947-004 | FENTORA | EQ 0.6MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021947-005 | FENTORA | EQ 0.8MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021947-006 | FENTORA | EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / BUCCAL, SUBLINGUAL | RLD | 2007-03-02 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021947-001 | FENTORA | EQ 0.1MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021947-002 | FENTORA | EQ 0.2MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021947-003 | FENTORA | EQ 0.4MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021947-004 | FENTORA | EQ 0.6MG BASE | TABLET / BUCCAL, SUBLINGUAL | RLD | 2006-09-25 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N021947-001 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N021947-002 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N021947-003 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N021947-004 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N021947-005 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N021947-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N021947-002 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N021947-003 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N021947-004 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N021947-005 | AB | 1 | e64feba35796… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021947-001 | 7862832 | 2028-06-15 | Drug product | 2011-04-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021947-001 | 7862833 | 2028-06-15 | Drug product | 2011-04-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021947-002 | 7862832 | 2028-06-15 | Drug product | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021947-002 | 7862833 | 2028-06-15 | Drug product | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021947-003 | 7862832 | 2028-06-15 | Drug product | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021947-003 | 7862833 | 2028-06-15 | Drug product | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021947-004 | 7862832 | 2028-06-15 | Drug product | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021947-004 | 7862833 | 2028-06-15 | Drug product | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021947-005 | 7862832 | 2028-06-15 | Drug product | 2011-04-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021947-005 | 7862833 | 2028-06-15 | Drug product | 2011-04-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-001 | 7862832 | 2028-06-15 | Drug product | 2011-04-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-001 | 7862833 | 2028-06-15 | Drug product | 2011-04-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-002 | 7862832 | 2028-06-15 | Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-002 | 7862833 | 2028-06-15 | Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-003 | 7862832 | 2028-06-15 | Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-003 | 7862833 | 2028-06-15 | Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-004 | 7862832 | 2028-06-15 | Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-004 | 7862833 | 2028-06-15 | Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-005 | 7862832 | 2028-06-15 | Drug product | 2011-04-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021947-005 | 7862833 | 2028-06-15 | Drug product | 2011-04-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021947-001 | 7862832 | 2028-06-15 | Drug product | 2011-04-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021947-001 | 7862833 | 2028-06-15 | Drug product | 2011-04-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021947-002 | 7862832 | 2028-06-15 | Drug product | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021947-002 | 7862833 | 2028-06-15 | Drug product | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021947-003 | 7862832 | 2028-06-15 | Drug product | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021947-003 | 7862833 | 2028-06-15 | Drug product | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021947-004 | 7862832 | 2028-06-15 | Drug product | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021947-004 | 7862833 | 2028-06-15 | Drug product | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021947-005 | 7862832 | 2028-06-15 | Drug product | 2011-04-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021947-005 | 7862833 | 2028-06-15 | Drug product | 2011-04-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-001 | 7862832 | 2028-06-15 | Drug product | 2011-04-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-001 | 7862833 | 2028-06-15 | Drug product | 2011-04-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-002 | 7862832 | 2028-06-15 | Drug product | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-002 | 7862833 | 2028-06-15 | Drug product | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-003 | 7862832 | 2028-06-15 | Drug product | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-003 | 7862833 | 2028-06-15 | Drug product | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-004 | 7862832 | 2028-06-15 | Drug product | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-004 | 7862833 | 2028-06-15 | Drug product | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-005 | 7862832 | 2028-06-15 | Drug product | 2011-04-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021947-005 | 7862833 | 2028-06-15 | Drug product | 2011-04-25 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FENTANYL CITRATE | FENTANYL CITRATE | Hospira, Inc. | 1ed25b2c-334e-4021-ada1-3396f07630dc | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | FENTANYL CITRATE |
| Fentanyl Citrate | FENTANYL CITRATE | Hikma Pharmaceuticals USA Inc. | ce5db1c2-feb1-4ad2-847a-d02e865bd47e | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | FENTANYL CITRATE |
| Fentanyl Citrate | FENTANYL CITRATE | Hospira, Inc. | bfa8018a-4cbc-434b-e09e-782872b0340a | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | FENTANYL CITRATE |
| Fentanyl Citrate | FENTANYL CITRATE | Teva Pharmaceuticals USA, Inc. | 78221eab-66fd-4cd8-9c81-af52eb83671c | 2026-01-31 | Boxed warning, Warnings, Adverse reactions | FENTANYL CITRATE |
| Fentanyl Citrate | FENTANYL CITRATE | Civica, Inc. | aacf276b-e133-4199-ad3f-67b894744c04 | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | FENTANYL CITRATE |
| Fentanyl Citrate | FENTANYL CITRATE | Phlow Corp. | 58dcd3f7-e3d8-4929-a186-8f680a51ff11 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | FENTANYL CITRATE |
| Fentanyl Citrate | FENTANYL CITRATE | Hikma Pharmaceuticals USA Inc. | c5fcdcbd-1dd1-4ebf-aa0d-edfe845414b7 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | FENTANYL CITRATE |
| Fentanyl Citrate | FENTANYL CITRATE | Fresenius Kabi USA, LLC | 0c10e465-4117-48ba-a454-23ccb7a3fcc7 | 2025-09-24 | Boxed warning, Warnings, Adverse reactions | FENTANYL CITRATE |
| Fentanyl Citrate | FENTANYL CITRATE | Fresenius Kabi USA, LLC | 38d0c14a-a0c1-44cc-a939-0304eb8037d6 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | FENTANYL CITRATE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51862-634 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-634 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-634 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-634 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-635 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-635 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-635 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-635 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-636 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-636 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-636 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-636 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-637 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-637 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-637 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-637 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-638 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-638 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-638 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 51862-638 | Fentanyl Buccal | Fentanyl Citrate | Mayne Pharma | NDA AUTHORIZED GENERIC | Current |
| 63459-541 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-541 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-541 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-541 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-541 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-541 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-541 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-541 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-541 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-542 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-542 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-542 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-542 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-542 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-542 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-542 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-542 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-542 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-544 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-544 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-544 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-544 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-544 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-544 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-544 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-544 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-544 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-546 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-546 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-546 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-546 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-546 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-546 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-546 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-546 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-546 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-548 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-548 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-548 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-548 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-548 | FENTORA | Fentanyl | Cephalon, LLC | NDA | Current |
| 63459-548 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-548 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-548 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
| 63459-548 | FENTORA | Fentanyl | Cephalon, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 84688 | SUPPL | 2026-01-06 |
| 84604 | SUPPL | 2025-12-31 |
| 79502 | SUPPL | 2024-08-29 |
| 77006 | SUPPL | 2023-12-19 |
| 76918 | SUPPL | 2023-12-18 |
| 76917 | SUPPL | 2023-12-18 |
| 72848 | SUPPL | 2022-12-09 |
| 72708 | SUPPL | 2022-11-25 |
| 72679 | SUPPL | 2022-11-23 |
| 72678 | SUPPL | 2022-11-23 |
| 71845 | SUPPL | 2022-08-18 |
| 69494 | SUPPL | 2021-12-07 |
| 66599 | SUPPL | 2021-03-08 |
| 66598 | SUPPL | 2021-03-08 |
| 66554 | SUPPL | 2021-03-05 |
| 65768 | SUPPL | 2020-12-28 |
| 60490 | SUPPL | 2019-10-09 |
| 60489 | SUPPL | 2019-10-09 |
| 60440 | SUPPL | 2019-10-09 |
| 49712 | SUPPL | 2017-09-11 |
| 48027 | SUPPL | 2017-04-14 |
| 47996 | SUPPL | 2017-04-12 |
| 46349 | SUPPL | 2016-12-21 |
| 46348 | SUPPL | 2016-12-21 |
| 46294 | SUPPL | 2016-12-20 |
| 46293 | SUPPL | 2016-12-20 |
| 28909 | SUPPL | 2014-12-30 |
| 28908 | SUPPL | 2013-11-12 |
| 16625 | SUPPL | 2013-02-26 |
| 28905 | SUPPL | 2013-02-25 |
| 16628 | SUPPL | 2012-06-11 |
| 28907 | SUPPL | 2012-06-07 |
| 6522 | SUPPL | 2012-01-03 |
| 44487 | ORIG | 2011-12-30 |
| 37938 | SUPPL | 2011-12-28 |
| 37937 | SUPPL | 2011-07-21 |
| 28906 | SUPPL | 2011-07-21 |
| 6521 | SUPPL | 2011-01-25 |
| 16627 | SUPPL | 2011-01-24 |
| 6520 | SUPPL | 2010-01-25 |
| 16626 | SUPPL | 2009-12-11 |
| 16624 | SUPPL | 2008-02-14 |
| 6519 | SUPPL | 2008-02-14 |
| 42355 | ORIG | 2007-12-06 |
| 23687 | ORIG | 2007-09-26 |
| 37936 | SUPPL | 2007-05-01 |
| 6518 | SUPPL | 2007-05-01 |
| 28904 | SUPPL | 2007-03-07 |
| 16623 | SUPPL | 2007-03-07 |
| 6517 | ORIG | 2006-10-02 |
| 37935 | ORIG | 2006-09-26 |